Latest Breaking News On - Therapeutic solutions international inc - Page 9 : vimarsana.com

Therapeutic Solutions International Utilizes Mesenchymal Stem Cell Exosomes to Effectively Suppress Neutrophil Extracellular Trap Production

/PRNewswire/ Therapeutic Solutions International, Inc., (OTC Markets: TSOI) announced today laboratory data demonstrating that exosomes produced by.

United statesTimothy dixonJames veltmeyerCompany phaseTherapeutic solutions international incTherapeutic solutions internationalChief medical officerBig pharmaSolutions international

Therapeutic Solutions International Utilizes Mesenchymal Stem Cell Exosomes to Effectively Suppress Neutrophil Extracellular Trap Production

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesTimothy dixonJames veltmeyerCompany phaseTherapeutic solutions international incTherapeutic solutions internationalPrnewswire therapeutic solutions international incSolutions internationalChief medical officerBig pharmaCoronavirus pandemicPr newswire

Therapeutic Solutions International Identifies and Files Patent on Combination Effects Between its Nutraceutical QuadraMune™ and Ivermectin in Animal Models of COVID-19 Pathology

Therapeutic Solutions International Identifies and Files Patent on Combination Effects Between its Nutraceutical QuadraMune™ and Ivermectin in Animal Models of COVID-19 Pathology
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesTimothy dixonJames veltmeyerTherapeutic solutions international incJadicell programTherapeutic solutions internationalChief medical officerCell programWais kaihaniSolutions internationalஒன்றுபட்டது மாநிலங்களில்தீமோத்தேயு டிக்சன்சிகிச்சை தீர்வுகள் சர்வதேச இன்க்சிகிச்சை தீர்வுகள் சர்வதேசதலைமை மருத்துவ அதிகாரிசெல் ப்ரோக்ர்யாம்

Therapeutic Solutions International Engages Venvalo Group to Oversee JadiCell COVID-19 Phase III Clinical Trial and Emergency Use Authorization (EUA) Process

Therapeutic Solutions International Engages Venvalo Group to Oversee JadiCell COVID-19 Phase III Clinical Trial and Emergency Use Authorization (EUA) Process
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesTimothy dixonBoris reznikCamillo ricordiTherapeutic solutions international incVenvalo groupTherapeutic solutions internationalPrincipal investigatorMedical visionaryEmergency use applicationTherapeutic solutions

Therapeutic Solutions International Recruits Pharmaceutical Industry Veteran Dr Boris Reznik to Accelerate Value Optimization of FDA Cleared Phase III COVID JadiCell™ Clinical Trial

Therapeutic Solutions International Recruits Pharmaceutical Industry Veteran Dr Boris Reznik to Accelerate Value Optimization of FDA Cleared Phase III COVID JadiCell™ Clinical Trial
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesTimothy dixonBoris reznikTherapeutic solutions international incVenvalo groupCompany advisory boardTherapeutic solutions internationalAdvisory boardSolutions internationalஒன்றுபட்டது மாநிலங்களில்தீமோத்தேயு டிக்சன்சிகிச்சை தீர்வுகள் சர்வதேச இன்க்சிகிச்சை தீர்வுகள் சர்வதேசதீர்வுகள் சர்வதேச